Summary & Overview
CPT 90480: SARS–CoV–2 Vaccine, First or Only Component
CPT code 90480 denotes the intramuscular administration of the first or sole component of a SARS–CoV–2 (COVID–19) vaccine. As a primary billing element for initial vaccine encounters, this code is central to documenting and reimbursing COVID‑19 immunization events across outpatient and ambulatory care settings. Nationally, accurate use of this code supports public health reporting, vaccine uptake monitoring, and consistent payment for vaccine administration services.
Key payers in the scope of this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for intramuscular COVID‑19 vaccine administration, typical sites of service where CPT code 90480 is used, and common billing practices associated with initial-dose vaccine administration. The publication also covers benchmarks and policy updates relevant to billing and coverage for COVID‑19 vaccine administration, as well as operational considerations for documenting the first or only vaccine component. Information absent from the input—such as detailed payer-specific coverage rules, associated taxonomies, and ICD‑10 diagnosis pairings—is noted as not available in the input.
Billing Code Overview
CPT code 90480 describes the administration of the first or only component of a SARS–CoV–2 (COVID–19) vaccine by intramuscular injection to reduce the patient's risk of contracting COVID–19. This procedure represents a single vaccine administration event when the vaccine regimen requires one dose or when documenting the initial dose in a multi-dose series.
-
Service type: Vaccine administration by intramuscular injection
-
Typical site of service: Outpatient clinics, physician offices, public health vaccination sites, pharmacy-based clinics, and other ambulatory care settings
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient presents to a primary care clinic during a seasonal vaccination drive requesting protection against SARS–CoV–2. The patient is screened for contraindications and vaccine history, consents to immunization, and is assigned to a medical assistant or nurse for administration. The provider documents vaccine manufacturer, lot number, expiration date, route (intramuscular), anatomical site (typically deltoid), and the VIS version and date in the medical record. The encounter includes verification of eligibility, counseling on common side effects, observation time as indicated, and electronic or paper reporting to the state immunization registry. Billing uses 90480 for the first or only administered COVID-19 vaccine component; vaccine product and administration supplies are reported separately when required by payer policies. Typical sites of service are outpatient primary care offices, community vaccination clinics, pharmacies (when clinic-based providers administer), and federally qualified health centers. A realistic workflow: patient check-in → screening and consent → vaccine preparation → administration using 90480 → post-vaccination observation and documentation → billing and immunization reporting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier; standard reporting |